The DKK3 Knockout HAP1 Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the human DKK3 tumor suppressor gene. This loss-of-function model enables interrogation of DKK3??s roles as a secreted Wnt antagonist in a defined genetic background, and the polyclonal format preserves editing diversity for unbiased phenotypic analysis.
The HAP1 host cell line is a near-haploid chronic myeloid leukemia (CML) derivative of the KBM-7 cell line, providing a simplified genetic landscape that facilitates straightforward interpretation of knockout phenotypes in an oncologically relevant context. The haploid genome reduces genetic complexity, making it particularly suitable for genetic screens and pathway analysis.
DKK3 encodes a secreted glycoprotein that functions primarily as a negative regulator of the canonical Wnt/??-catenin signaling pathway. Mechanistically, DKK3 antagonizes Wnt signaling by preventing the nuclear translocation of ??-catenin and promoting its degradation, thereby inhibiting the transcription of Wnt target genes such as MYC and CCND1. In the canonical Wnt cascade, DKK3 interferes with the signaling complex that includes Frizzled receptors and LRP5/6 co-receptors, ultimately reducing ??-catenin stabilization and TCF/LEF-mediated transcription. The gene??s expression is regulated by tumor protein p53 (TP53), AP-1 transcription factors, and epigenetic silencing through DNA methylation. In parallel, DKK3 activates the JNK pathway by engaging MAPK8 and c-Jun, leading to BAX-dependent apoptosis, and modulates TGF-?? signaling via interactions with TGF-?? receptors and downstream SMAD2/3 effectors, integrating multiple tumor-suppressive networks.
In the HAP1 leukemic background, loss of DKK3 is expected to derepress canonical Wnt/??-catenin activity, reflecting its tumor-suppressive function frequently silenced in prostate, breast, and glioblastoma cancers. This model enables dissection of Wnt-driven proliferation and JNK-mediated apoptosis, with assays such as western blotting for ??-catenin, TOPFlash luciferase reporter, and Annexin V apoptosis detection directly linking pathway activity to functional outcomes. Furthermore, given the near-haploid nature of HAP1 cells, the model is especially suitable for synthetic lethality or epistasis screens, where precise genetic interactions can be probed with minimal background noise.
This knockout cell pool supports advanced studies including Wnt pathway inhibition, tumor suppression mechanisms, cancer epigenetics, and JNK-mediated apoptosis. Compatible techniques encompass RT-qPCR for Wnt target genes, migration and invasion assays, and bisulfite sequencing for DNA methylation analysis. The product offers a versatile platform for translational oncology and developmental biology. For technical inquiries, contact Ascent Research.
